Recurrent pancreatitis in mitochondrial cytopathy

American Journal of Medical Genetics, Part A

Volumn 140, Issue 21, 2006, Pages 2330-2335

  Debray, François Guillaume ^a   Drouin, Eric ^a   Herzog, Denise ^a   Lortie, Anne ^a   Lambert, Marie ^a   Garel, Laurent ^a   Mitchell, Grant A ^a   Michaud, Jacques L ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Kearns Sayre; Mitochondria; mtDNA; Pancreatitis

Indexed keywords

ABDOMINAL PAIN; ACUTE PANCREATITIS; ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; HUMAN; KEARNS SAYRE SYNDROME; MALE; MITOCHONDRIAL RESPIRATION; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RECURRENT DISEASE;

ACUTE DISEASE; ADOLESCENT; DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; HUMANS; KEARNS-SAYER SYNDROME; MALE; PANCREATIC PSEUDOCYST; PANCREATITIS; RECURRENCE; SEQUENCE DELETION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33750586270     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.31457     Document Type: Article

References (36)

1. Baerlocher KE, Feldges A, Weissert M, Simonsz HJ, Rotig A. 1992. Mitochondrial DNA deletion in an 8-year-old boy with Pearson syndrome. J Inher Metab Dis 15:327-330.
2. Ballinger SW, Shoffner JM, Hedaya EV, Trounce I, Polak MA, Koontz DA, Wallace DC. 1992. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nat Genet 1:11-15.
3. Baudin H, Colin M, Dumont EJ. 1909. Energy sources for protein synthesis and enzymatic secretion in rat pancreas in vitro. Biochem Biophys Acta 174:722-733.
4. Bernier FP, Boneh A, Dennett X, Chow CW, Cleary MA, Thorburn DR. 2002. Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 59:1400-1411.
5. Birkus G, Hitchcock MJM, Cihlar T. 2002. Assessment of mitochondrial toxicity in human cells treated with tenofovir: Comparison with other nucleoside reverse transcriptase inhibitors. Antimicrob Agents Chemother 46:716-723.
6. Bolender RP. 1974. Stereological analysis of the guinea pig pancreas. I. Analytical model and quantitative description of non stimulated pancreatic exocrine cells. J Cell Biol 61:269-287.
7. Cote HC, Brumme ZL, Craib KJ, Alexander CS, Wynhoven B, Ting L, Wong H, Harris M, Harrigan PR, O'Shaughnessy MV, Montaner JS. 2002. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N Engl J Med 346:811-820.
8. Creighton J, Lyall R, Wilson DI, Curtis A, Charnley R. 1999. Mutations of the cationic trypsinogen gene in patients with chronic pancreatitis. Lancet 37:16-23.
9. Dougherty FE, Ernst SG, Aprille JR. 1994. Familial recurrence of atypical symptoms in an extended pedigree with the syndrome of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). J Pediatr 125:758-761.
10. Ehlers RA, Hernandez A, Bloemendal LS, Ethridge RT, Farrow B, Evers BM. 1999. Mitochondrial DNA damage and altered membrane potential in pancreatic acinar cells induced by reactive oxygen species. Surgery 126:148-155.
11. Foli A, Benvenuto F, Piccinini G, Bareggi A, Cossarizza A, Lisziewicz J, Lori F. 2001. Direct analysis of mitochondrial toxicity of antiretroviral drugs. AIDS 15:1687-1694.
12. Geromel V, Kadhom N, Caebalos-Picot I, Ouari O, Polidori A, Munnich A, Rötig A, Rustin P. 2001. Superoxide-induced massive apoptosis in cultured skin fibroblasts harbouring the neurogenic ataxia retinitis pigmentosa (NARP) mutation in the ATPase-6 gene of the mitochondrial DNA. Hum Mol Genet 10:1221-1228.
13. Halangk W, Matthias R, Schild L, Meyer F, Schulz HU, Lippert H. 1998. Effect of supramaximal cerulein stimulation on mitochondrial energy metabolism in rat pancreas. Pancreas 16:88-95.
14. Johnston W, Karpati G, Carpenter S, Arnold D, Shoubridge EA. 1995. Late-onset mitochondrial myopathy. Ann Neurol 37:16-23.
15. Kahler SG, Sherwood WG, Woolf D, Lawless ST, Zaritsky A, Bonham J, Taylor CJ, Clarke JTR, Durie P, Leonard JV. 1994. Pancreatitis in patients with organic acidemia. J Pediatr 124:239-243.
16. Kakuda TN. 2000. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Therap 22:685-708.
17. Kato S, Miyabayashi S, Ohi R, Nakagawa H, Abe J, Yamamoto K, Watanabe S, Tada K. 1990. Chronic pancreatitis in muscular cytochrome c oxidase deficiency. J Pediatr Gastroenterolog Nutr 11:549-552.
18. Kishnani PS, Van Hove JLK, Shoffner JS, Kaufman A, Bossen EH, Kahler SG. 1996. Acute pancreatitis in an infant with lactic acidosis and a mutation at nucleotide 3243 in the mitochondrial DNA tRNALeu(UUR) gene. Eur J Ped 155:898-903.
19. Kosowski H, Schild L, Dagmar K, Halangk W. 1998. Energy metabolism in rat pancreatic acinar cells during anoxia and reoxygenation. Biochem Biophys Acta 1367:118-126.
20. Luthen R, Niederau C, Grendell JH. 1995. Intrapancreatic zymogen activation and levels of ATP and glutathione during caerulein pancreatitis in rats. Am J Physiol 268:G592-G604.
21. McComsey G, Lonergan JT. 2004. Mitochondrial dysfunction: Patient monitoring and toxicity management. J Acq Immune Defic Syndr 37:S30-S35.
22. Munnich A, Rotig A, Chretien D, Saudubray JM, Cormier V, Rustin P. 1996. Clinical presentations and laboratory investigations in respiratory chain deficiency. Eur J Pediatr 155:262-274.
23. Oexle K, Oberle J, Finckh B, Kohlschutter A, Nagy M, Seibel P, Seissler J, Hubner C. 1996. Islet cell antibodies in diabetes mellitus associated with a mitochondrial tRNALeu(UUR) gene mutation. Exp Clin Endocrinol Diabetes 104:212-217.
24. Raha S, Robinson BH. 2001. Mitochondria, oxygen free radicals, and apoptosis. Am J Med Genet 106:62-70.
25. Robertson MA. 2000. Acute and chronic pancreatitis. In: Walker WA, Durie PR, Hamilton JR, Walker-Smith JA, Watkins JB, editors. Pediatric gastrointestinal disease. 3th edition. Hamilton: BC Decker, Inc. p 1321-1344.
26. Rötig A, Bourgeron T, Chretien D, Rustin P, Munnich A. 1995. Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. Hum Mol Genet 4:1327-1330.
27. Rozen R, Ferreira-Rajabi L, Robb L, Colman N. 1995. L206W mutation of the cystic fibrosis gene, relatively frequent in French Canadians, is associated with atypical presentations of cystic fibrosis. Am J Med Genet 57:437-439.
28. Schon EA, Rizzuto R, Moraes CT, Nakase H, Zeviani M, DiMauro S. 1989. A direct repeat is a hotspot for large-scale deletion of human mitochondrial DNA. Science 244:346-349.
29. Toyono M, Nakano K, Kiuchi M, Imai K, Suzuki H, Shishikura K, Osawa M, Shiratori K, Goto Y, Nonaka I, Sugie H. 2001. A case of MERRF associated with chronic pancreatitis. Neuromusc Disord 11:300-304.
30. Tsai K, Wang SS, Chen TS, Kong CW, Chang FY, Lee SD, Lu FJ. 1998. Oxidative stress: An important phenomena with pathogenic significance in the progression of acute pancreatitis. Gut 42:850-855.
31. Tsao CY, Mendell JR, Luquette M, Dixon B, Morrow G. 2000. Mitochondrial DNA depletion in children. J Child Neurol 15:822-824.
32. van den Ouweland JMW, Lemkes HHPJ, Ruitenbeek W, Sandkuijl LA, de Vijlder MF, Struyvenberg PAA, van de Kamp JJP, Maassen JA. 1992. Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1:368-371.
33. Van Goethem G, Dermaut B, Lofgren A, Martin J-J, Van Broeckhoven C. 2001. Mutation of POLG is associated with progressive external ophtalmoplegia characterized by mtDNA deletions. Nat Genet 28:211-212.
34. Wallace DC, Lott MT, Brown MD, Kerstann K. 2001. Mitochondrial and neuro-ophtalmologic diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D, et al. editors. The metabolic and molecular bases of inherited disease. 8th edition. New York: McGraw-Hill. p 2425-2509.
35. Wang H, Lemire BD, Cass CE, Weiner JH, Michalak M, Penn AM, Fliegel L. 1996. Zidovudine and dideoxynucleosides deplete wild-type mitochondrial DNA levels and increase deleted mitochondrial DNA levels in cultured Kearns-Sayre syndrome fibroblasts. Biochim Biophys Acta 1316:51-59.
36. Witt H, Luck W, Hennies HC, Classen M, Kage A, Lass U, Landt O, Becker M. 2000. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 25:213-216.